1. Pallansch, M. A., Oberste, M. S. & Whitton, J. L. In Fields virology (eds David, M. Knipe & Peter, M. Howley) 490–530 (Wolters Kluwer/Lippincott Williams & Wilkins Health, 2013).
2. Chang, L. Y. et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354, 1682–1686, https://doi.org/10.1016/S0140-6736(99)04434-7 (1999).
3. Xing, W. et al. Hand, foot, and mouth disease in China, 2008–12: an epidemiological study. The Lancet Infectious Diseases 14, 308–318, https://doi.org/10.1016/s1473-3099(13)70342-6 (2014).
4. Hassel, C. et al. Transmission patterns of human enterovirus 71 to, from and among European countries, 2003 to 2013. Eurosurveillance 20, 2–12, https://doi.org/10.2807/1560-7917.Es.2015.20.34.30005 (2015).
5. Centers for Disease Control and Prevention. Notes from the field: severe hand, foot, and mouth disease associated with coxsackievirus A6 - Alabama, Connecticut, California, and Nevada, November 2011-February 2012. MMWR Morb Mortal Wkly Rep 61, 213–214 (2012).